These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36141710)

  • 1. Atypical Hemolytic Uremic Syndrome after SARS-CoV-2 Infection: Report of Two Cases.
    Smarz-Widelska I; Syroka-Główka M; Janowska-Jaremek J; Kozioł MM; Załuska W
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A hemolytic episode following COVID-19 in a case with atypical hemolytic uremic syndrome].
    Suzuki K; Nagaharu K; Hachiya K; Nishimura K; Matsumoto T; Tawara I
    Rinsho Ketsueki; 2022; 63(3):224-228. PubMed ID: 35387937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report.
    Claes KJ; Geerts I; Lemahieu W; Wilmer A; Kuypers DRJ; Koshy P; Ombelet S
    Am J Kidney Dis; 2023 Mar; 81(3):364-367. PubMed ID: 36342000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report.
    Rysava R; Peiskerova M; Tesar V; Benes J; Kment M; Szilágyi Á; Csuka D; Prohászka Z
    Front Immunol; 2022; 13():1001366. PubMed ID: 36275662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Ito S; Hidaka Y; Inoue N; Kaname S; Kato H; Matsumoto M; Miyakawa Y; Mizuno M; Okada H; Shimono A; Matsuda T; Maruyama S; Fujimura Y; Nangaku M; Kagami S
    Clin Exp Nephrol; 2019 Jan; 23(1):112-121. PubMed ID: 30039480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical hemolytic uremic syndrome induced by SARS-CoV2 infection in infants with EXOSC3 mutation.
    Van Quekelberghe C; Latta K; Kunzmann S; Grohmann M; Hansen M
    Pediatr Nephrol; 2022 Nov; 37(11):2781-2784. PubMed ID: 35522339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccination and Atypical hemolytic uremic syndrome.
    Bouwmeester RN; Bormans EMG; Duineveld C; van Zuilen AD; van de Logt AE; Wetzels JFM; van de Kar NCAJ
    Front Immunol; 2022; 13():1056153. PubMed ID: 36531998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.
    Fakhouri F; Hourmant M; Campistol JM; Cataland SR; Espinosa M; Gaber AO; Menne J; Minetti EE; Provôt F; Rondeau E; Ruggenenti P; Weekers LE; Ogawa M; Bedrosian CL; Legendre CM
    Am J Kidney Dis; 2016 Jul; 68(1):84-93. PubMed ID: 27012908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination.
    Aigner C; Gaggl M; Schmidt S; Kain R; Kozakowski N; Oszwald A; Prohászka Z; Sunder-Plassmann R; Schmidt A; Sunder-Plassmann G
    Kidney Int Rep; 2023 May; 8(8):1506-13. PubMed ID: 37360817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R
    Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathy after kidney transplantation: Analysis of the Brazilian Atypical Hemolytic Uremic Syndrome cohort.
    Nga HS; Palma LMP; Ernandes Neto M; Fernandes-Charpiot IMM; Garcia VD; Kist R; Miranda SMC; Macedo de Souza PA; Pereira GM; de Andrade LGM
    PLoS One; 2021; 16(11):e0258319. PubMed ID: 34748552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Kato H; Miyakawa Y; Hidaka Y; Inoue N; Ito S; Kagami S; Kaname S; Matsumoto M; Mizuno M; Matsuda T; Shimono A; Maruyama S; Fujimura Y; Nangaku M; Okada H
    Clin Exp Nephrol; 2019 Jan; 23(1):65-75. PubMed ID: 29959568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-factor H antibody associated hemolytic uremic syndrome following SARS-CoV-2 infection.
    Khandelwal P; Krishnasamy S; Govindarajan S; Kumar M; Marik B; Sinha A; Hari P; Bagga A
    Pediatr Nephrol; 2022 Sep; 37(9):2151-2156. PubMed ID: 35089377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.
    Asif A; Nayer A; Haas CS
    J Nephrol; 2017 Jun; 30(3):347-362. PubMed ID: 27848226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM
    Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case series: coronavirus disease 2019 infection as a precipitant of atypical hemolytic uremic syndrome: two case reports.
    Kurian CJ; French Z; Kukulich P; Lankiewicz M; Ghimire S; Maarouf OH; Rizk S; Rhoades R
    J Med Case Rep; 2021 Dec; 15(1):587. PubMed ID: 34903272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey.
    Gediz F; Payzin BK; Ecemis S; Güler N; Yilmaz AF; Topcugil F; Berdeli A
    Transfus Apher Sci; 2016 Dec; 55(3):357-362. PubMed ID: 27742267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a scoring system in Japanese patients diagnosed with atypical hemolytic uremic syndrome to assess the relationship between the score and clinical responses to eculizumab.
    Wada H; Teranishi H; Shimono A; Kato N; Maruyama S; Matsumoto M
    Thromb J; 2023 Apr; 21(1):43. PubMed ID: 37072821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS-CoV2 vaccine mRNA-1273: A case report with literature revision.
    Moronti V; Carubbi F; Sollima L; Piscitani L; Ferri C
    Medicine (Baltimore); 2023 Dec; 102(50):e36560. PubMed ID: 38115241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.